Mohammad R. Nowrousian

947 total citations
31 papers, 693 citations indexed

About

Mohammad R. Nowrousian is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Mohammad R. Nowrousian has authored 31 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 12 papers in Oncology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Mohammad R. Nowrousian's work include Multiple Myeloma Research and Treatments (10 papers), Lymphoma Diagnosis and Treatment (7 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Mohammad R. Nowrousian is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Lymphoma Diagnosis and Treatment (7 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). Mohammad R. Nowrousian collaborates with scholars based in Germany, United States and United Kingdom. Mohammad R. Nowrousian's co-authors include S. Seeber, Peter R. Ebeling, Bertram Opalka, Dieter Brandhorst, P. Hilgard, Ulrike Buttkereit, Barbara Bertram, Manfred Wießler, Philipp Schütt and C. G. Schmidt and has published in prestigious journals such as Blood, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Mohammad R. Nowrousian

30 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad R. Nowrousian Germany 15 359 245 237 134 114 31 693
Peter Ernst Saudi Arabia 16 347 1.0× 288 1.2× 204 0.9× 96 0.7× 115 1.0× 40 816
Israel Bendit Brazil 17 423 1.2× 197 0.8× 208 0.9× 84 0.6× 296 2.6× 82 818
Andrija Bogdanović Serbia 17 466 1.3× 294 1.2× 141 0.6× 130 1.0× 279 2.4× 96 894
Sonja Mandl–Weber Germany 16 241 0.7× 511 2.1× 225 0.9× 153 1.1× 117 1.0× 26 921
M.S. Gordon United States 14 212 0.6× 309 1.3× 212 0.9× 80 0.6× 115 1.0× 89 686
Isabelle Genvresse Germany 12 169 0.5× 107 0.4× 157 0.7× 104 0.8× 99 0.9× 27 472
Betty Glinsmann‐Gibson United States 15 409 1.1× 422 1.7× 272 1.1× 105 0.8× 146 1.3× 23 853
B G M Durie United States 10 357 1.0× 584 2.4× 746 3.1× 81 0.6× 74 0.6× 18 1.1k
Nishant Tageja United States 15 212 0.6× 188 0.8× 163 0.7× 76 0.6× 115 1.0× 33 516
Z Estrov United States 15 631 1.8× 335 1.4× 287 1.2× 67 0.5× 330 2.9× 17 1.1k

Countries citing papers authored by Mohammad R. Nowrousian

Since Specialization
Citations

This map shows the geographic impact of Mohammad R. Nowrousian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad R. Nowrousian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad R. Nowrousian more than expected).

Fields of papers citing papers by Mohammad R. Nowrousian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad R. Nowrousian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad R. Nowrousian. The network helps show where Mohammad R. Nowrousian may publish in the future.

Co-authorship network of co-authors of Mohammad R. Nowrousian

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad R. Nowrousian. A scholar is included among the top collaborators of Mohammad R. Nowrousian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad R. Nowrousian. Mohammad R. Nowrousian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schütt, Philipp, Vera Rebmann, Dieter Brandhorst, et al.. (2008). The clinical significance of soluble human leukocyte antitgen class-I, ICTP, and RANKL molecules in multiple myeloma patients. Human Immunology. 69(2). 79–87. 14 indexed citations
2.
Nowrousian, Mohammad R., Jürgen Dunst, & Peter Vaupel. (2008). Erythropoiesis-Stimulating Agents: Favorable Safety Profile When Used as Indicated. Strahlentherapie und Onkologie. 184(3). 121–136. 13 indexed citations
3.
Stattaus, J., Hilmar Kuehl, K. Metz, et al.. (2008). Diagnostic Yield of Computed Tomography-Guided Coaxial Core Biopsy of Undetermined Masses in the Free Retroperitoneal Space: Single-Center Experience. CardioVascular and Interventional Radiology. 31(5). 919–925. 32 indexed citations
5.
Schütt, Philipp, Dieter Brandhorst, Peter R. Ebeling, et al.. (2006). Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections. Leukemia & lymphoma. 47(8). 1570–1582. 99 indexed citations
6.
Schütt, Philipp, Peter R. Ebeling, Ulrike Buttkereit, et al.. (2005). Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival. Annals of Hematology. 84(9). 594–600. 24 indexed citations
7.
Korfel, Agnieszka, Peter Martus, Mohammad R. Nowrousian, et al.. (2004). Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma. British Journal of Haematology. 128(2). 177–183. 41 indexed citations
8.
Buttkereit, Ulrike, Dieter Brandhorst, Monika Lindemann, et al.. (2004). In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment. Cancer Immunology Immunotherapy. 54(5). 506–512. 6 indexed citations
9.
Nowrousian, Mohammad R., Dieter Brandhorst, Peter R. Ebeling, et al.. (2003). Free light-chain measurement in serum compared with immunofixation of urine in patients with multiple myeloma. Blood. 102(11). 367. 2 indexed citations
10.
Nowrousian, Mohammad R., et al.. (2003). 581 Treatment with epoetin beta corrects anaemia and decreases transfusion use in patients with solid tumours or haemotological malignancies. European Journal of Cancer Supplements. 1(5). S176–S176. 2 indexed citations
11.
Nowrousian, Mohammad R.. (1998). Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.. PubMed. 15 Suppl 1. S19–28. 36 indexed citations
12.
Siebert, Reiner, Alexander Fosså, Anja Welt, et al.. (1997). Recurrence of hodgkin's disease after 10 or more years: Late relapse or de-Novo malignancy due to HLA-DPB1* 0301-linked susceptibility?. Leukemia & lymphoma. 26(1-2). 121–125. 3 indexed citations
13.
Siebert, Reiner, Christoph Willers, Alexander Fosså, et al.. (1996). Analysis of the novel cyclin-dependent kinase 4 and 6 inhibitor gene p18 in lymphoma and leukemia cell lines. Leukemia Research. 20(2). 197–200. 5 indexed citations
14.
Siebert, Reiner, Christoph Willers, Alexander Schramm, et al.. (1995). Homozygous loss of the MTSl/pl6 and MTS2/pl5 genes in lymphoma and lymphoblastic leukaemia cell lines. British Journal of Haematology. 91(2). 350–354. 20 indexed citations
15.
Müller, Mark, Klaus Lennartz, Mohammad R. Nowrousian, et al.. (1994). Improved flow‐cytometric detection of low P‐glycoprotein expression in leukaemic blasts by histogram subtraction analysis. Cytometry. 15(1). 64–72. 19 indexed citations
17.
Nowrousian, Mohammad R., N. Niederle, M. Nagel‐Hiemke, et al.. (1991). Etoposide, ifosfamide, and methotrexate with or without bleomycin in refractory or recurrent lymphomas. Annals of Oncology. 2. 25–30. 9 indexed citations
18.
Eisenbrand, Gerhard, Martin R. Berger, Mohammad R. Nowrousian, et al.. (1989). Nitrosoureas Modes of Action and Perspectives in the Use of Hormone Receptor Affine Carrier Molecules. Acta Oncologica. 28(2). 203–211. 12 indexed citations
19.
Nowrousian, Mohammad R. & P. Hilgard. (1978). Low-dose heparin in the management of acute myelocytic leukaemia. Annals of Hematology. 37(6). 341–343. 2 indexed citations
20.
Nowrousian, Mohammad R., et al.. (1973). Die klinische Bedeutung der Vitamin-B12-Bestimmung im Serum. Ein Vergleich mit dem Schilling-Test. Annals of Hematology. 27(2). 99–104. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026